| 2025-03-21 | -41.7% | earnings | Seeking Alpha | Tela Bio slumps after Q4 miss as Piper Sandler downgrades |
| 2025-03-21 | -41.7% | earnings | Seeking Alpha | TELA Bio, Inc. 2024 Q4 - Results - Earnings Call Presentation |
| 2025-03-21 | -41.7% | earnings | Seeking Alpha | TELA Bio sees 23-27% revenue growth for 2025 with expanded sales strategy |
| 2025-03-21 | -41.7% | earnings | Seeking Alpha | TELA Bio, Inc. (TELA) Q4 2024 Earnings Call Transcript |
| 2025-03-21 | -41.7% | earnings | Yahoo Finance | TELA Bio Shares Drop 43% After Weak Q4 Growth, High Sales Turnover - Yahoo Finance |
| 2025-03-21 | -41.7% | news | Investing.com UK | Canaccord cuts TELA Bio stock target to $7, maintains Buy By Investing.com - Investing.com UK |
| 2025-03-20 | -37.2% | earnings | Seeking Alpha | TELA Bio GAAP EPS of -$0.23 misses by $0.01, revenue of $17.6M misses by $5.57M |
| 2025-03-20 | -37.2% | legal | SEC EDGAR | TELA 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-03-20 | -37.2% | earnings | Investing.com | Earnings call transcript: Tela Bio Q4 2024 misses earnings, stock drops - Investing.com |
| 2024-08-13 | -26.4% | earnings | Seeking Alpha | TELA Bio, Inc. (TELA) Q2 2024 Earnings Call Transcript |
| 2024-08-12 | -25.6% | earnings | Seeking Alpha | TELA Bio GAAP EPS of -$0.51 misses by $0.02, revenue of $16.1M misses by $2.36M |
| 2024-08-12 | -25.6% | legal | SEC EDGAR | TELA 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-03-27 | -22.2% | analyst | Investing.com | Citizens cuts Tela Bio stock price target on commercial transition - Investing.com |
| 2023-11-09 | -21.1% | legal | SEC EDGAR | TELA 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-04-15 | +20.7% | news | UBND thành phố Hải Phòng | TELA Bio (TELA) Stock Bonus Issue (Technical Strength) 2026-04-15 - High Interest Stocks - UBND thành phố Hải Phòng |
| 2025-11-17 | +19.9% | news | Stock Titan | TELA Bio (NASDAQ: TELA) grants 30,200 RSUs and 25,000 stock options as inducement awards - Stock Titan |
| 2024-05-09 | +19.5% | earnings | Seeking Alpha | TELA Bio GAAP EPS of -$0.23 beats by $0.29, revenue of $16.6M beats by $0.28M |
| 2024-05-09 | +19.5% | legal | SEC EDGAR | TELA 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-03-24 | -17.1% | earnings | Motley Fool | TELA Bio (TELA) Q4 2025 Earnings Call Transcript |
| 2026-03-24 | -17.1% | earnings | Zacks | TELA Bio, Inc. (TELA) Reports Q4 Loss, Lags Revenue Estimates |
| 2026-03-24 | -17.1% | earnings | MT Newswires | TELA Bio Q4 Net Loss Narrows, Revenue Rises |
| 2026-03-24 | -17.1% | news | GlobeNewswire | TELA Bio Reports Fourth Quarter and Full Year 2025 Financial Results |
| 2026-03-24 | -17.1% | earnings | Seeking Alpha | Tela Bio targets at least 8% revenue growth in 2026 while advancing commercial transformation |
| 2026-03-24 | -17.1% | earnings | Seeking Alpha | TELA Bio, Inc. (TELA) Q4 2025 Earnings Call Transcript |
| 2026-03-24 | -17.1% | earnings | Seeking Alpha | TELA Bio GAAP EPS of -$0.17 beats by $0.01, revenue of $20.9M misses by $0.14M |
| 2026-03-24 | -17.1% | legal | SEC EDGAR | TELA 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-03-24 | -17.1% | earnings | Yahoo Finance | TELA Bio, Inc. (TELA) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance |
| 2026-03-24 | -17.1% | news | GlobeNewswire | TELA Bio Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewswire |
| 2026-03-24 | -17.1% | news | Stock Titan | TELA Bio (NASDAQ: TELA) lifts 2025 sales 16% but posts $38.8M loss - Stock Titan |
| 2026-03-24 | -17.1% | earnings | TipRanks | TELA Bio Posts Record 2025 Revenue, Sets 2026 Outlook - TipRanks |
| 2026-04-06 | +15.1% | earnings | Cổng thông tin điện tử tỉnh Lào Cai | Can TELA Bio (TELA) Stock Beat the Market | Price at $0.63, Up 5.47% - Trading Ideas - Cổng thông tin điện tử tỉnh Lào Cai |
| 2023-04-18 | -14.3% | legal | SEC EDGAR | TELA 8-K: 2.02 (SEC Filing) |
| 2025-05-08 | +13.1% | earnings | Seeking Alpha | TELA Bio GAAP EPS of -$0.25 misses by $0.05, revenue of $18.5M beats by $1.15M |
| 2025-05-08 | +13.1% | legal | SEC EDGAR | TELA 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-01-09 | -12.5% | legal | SEC EDGAR | TELA 8-K: 8.01 and (SEC Filing) |
| 2023-04-19 | -12.3% | news | Latham & Watkins LLP | Latham & Watkins Advises on TELA Bio’s Public Offering of Common Stock - Latham & Watkins LLP |
| 2025-06-02 | +11.8% | legal | SEC EDGAR | TELA 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-03-10 | -11.6% | news | GlobeNewswire | TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results |
| 2026-03-10 | -11.6% | news | GlobeNewswire | TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results - GlobeNewswire |
| 2025-11-04 | -11.6% | news | Quiver Quantitative | TELA Bio, Inc. to Report Third Quarter 2025 Financial Results and Host Conference Call on November 13, 2025 - Quiver Quantitative |
| 2026-03-20 | +11.3% | news | Stock Titan | TELA Bio (TELA) hit with Nasdaq $1 bid-price deficiency, faces delisting risk - Stock Titan |
| 2025-11-13 | -10.7% | news | Seeking Alpha | TELA Bio prices $13M registered direct offering of common stock, pre-funded warrants |
| 2025-11-13 | -10.7% | earnings | Seeking Alpha | TELA Bio GAAP EPS of -$0.19 beats by $0.02, revenue of $20.7M misses by $1.08M |
| 2025-11-13 | -10.7% | legal | SEC EDGAR | TELA 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-11-13 | -10.7% | earnings | Yahoo Finance | TELA Bio, Inc. (TELA) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance |
| 2025-11-13 | -10.7% | news | GlobeNewswire | TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility - GlobeNewswire |
| 2022-11-09 | +10.4% | legal | SEC EDGAR | TELA 8-K: 2.02, 7.01 (SEC Filing) |
| 2022-11-09 | +10.4% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for TELA Bio (TELA) - Zacks Investment Research |
| 2026-03-19 | +10.0% | earnings | Zacks | Assembly Biosciences (ASMB) Q4 Earnings and Revenues Top Estimates |
| 2025-05-11 | -9.8% | earnings | Seeking Alpha | TELA Bio, Inc. (TELA) Q1 2025 Earnings Call Transcript |
| 2022-08-10 | -8.6% | legal | SEC EDGAR | TELA 8-K: 2.02 and (SEC Filing) |
| 2025-08-11 | -7.8% | earnings | Seeking Alpha | Tela Bio reiterates $85M–$88M 2025 revenue target as international expansion accelerates |
| 2025-08-11 | -7.8% | earnings | Seeking Alpha | TELA Bio, Inc. (TELA) Q2 2025 Earnings Call Transcript |
| 2025-08-11 | -7.8% | earnings | Seeking Alpha | TELA Bio GAAP EPS of -$0.22, revenue of $20.2M |
| 2025-08-11 | -7.8% | legal | SEC EDGAR | TELA 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-04-10 | -7.0% | news | UBND thành phố Hải Phòng | What is the sentiment around TELA Bio (TELA) Stock | Price at $0.59, Down 0.12% - Market Movers - UBND thành phố Hải Phòng |
| 2024-10-22 | +6.5% | news | Seeking Alpha | TELA Bio announces public offering of common stock, pre-funded warrants |
| 2024-10-22 | +6.5% | legal | SEC EDGAR | TELA 8-K: 2.02 and 7.01 (SEC Filing) |
| 2022-03-21 | -5.9% | legal | SEC EDGAR | TELA 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-11-03 | +5.9% | legal | SEC EDGAR | TELA 8-K: 5.02 (SEC Filing) |
| 2022-05-31 | -5.7% | legal | SEC EDGAR | TELA 8-K: 1.01, 1.02, 2.03 (SEC Filing) |
| 2026-03-22 | +5.6% | news | Seeking Alpha | Quant snapshot: AAR, Noah Holdings lead strong buys as Blaize, Fractyl Health lag |
| 2022-01-04 | -5.3% | legal | SEC EDGAR | TELA 8-K: 5.02 (SEC Filing) |
| 2025-11-12 | -5.1% | earnings | Yahoo Finance | TELA Bio Inc (TELA) Q3 2025 Earnings Report Preview: What To Expect - Yahoo Finance |
| 2026-04-03 | +5.1% | earnings | Cổng thông tin điện tử tỉnh Tây Ninh | TELA Q4 2025 Earnings: TELA Bio Inc. tops EPS views, no revenue logged - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2023-03-21 | -5.0% | legal | SEC EDGAR | TELA 8-K: 2.02, 7.01 (SEC Filing) |
| 2022-02-25 | +5.0% | news | GlobeNewswire | TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire |
| 2025-02-21 | -4.5% | news | GlobeNewswire | TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire |
| 2024-11-09 | -4.5% | earnings | Seeking Alpha | TELA Bio, Inc. (TELA) Q3 2024 Earnings Call Transcript |
| 2021-08-11 | +4.4% | legal | SEC EDGAR | TELA 8-K: 2.02, 7.01 (SEC Filing) |
| 2022-05-10 | -4.3% | legal | SEC EDGAR | TELA 8-K: 2.02, 7.01 (SEC Filing) |
| 2024-10-23 | +4.3% | news | Seeking Alpha | TELA Bio falls after pricing of public offering |
| 2024-10-23 | +4.3% | legal | SEC EDGAR | TELA 8-K: 1.01 and (SEC Filing) |
| 2024-10-23 | +4.3% | news | GlobeNewswire | TELA Bio Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewswire |
| 2023-08-09 | -4.1% | legal | SEC EDGAR | TELA 8-K: 2.02, 7.01 (SEC Filing) |
| 2022-11-04 | -4.1% | analyst | TradingView | TELA Forecast — Price Target — Prediction for 2027 - TradingView |
| 2025-05-30 | +4.0% | legal | SEC EDGAR | TELA 8-K: 5.02 and 5.07 (SEC Filing) |
| 2024-03-21 | +3.9% | earnings | Seeking Alpha | TELA Bio, Inc. (TELA) Q4 2023 Earnings Call Transcript |
| 2024-03-21 | +3.9% | earnings | Seeking Alpha | TELA Bio GAAP EPS of -$0.53 misses by $0.10, revenue of $17M beats by $0.61M |
| 2024-03-21 | +3.9% | expansion | Seeking Alpha | TELA Bio launches Liquifix surgical devices in the U.S. |
| 2024-03-21 | +3.9% | legal | SEC EDGAR | TELA 8-K: 2.02, 7.01, 8.01 (SEC Filing) |
| 2021-05-04 | -3.8% | legal | SEC EDGAR | TELA 8-K: 5.02 (SEC Filing) |
| 2025-11-14 | +3.7% | earnings | Seeking Alpha | Tela Bio outlines at least 16% 2025 revenue growth target while strengthening commercial team and balance sheet |
| 2025-11-14 | +3.7% | earnings | Seeking Alpha | TELA Bio, Inc. (TELA) Q3 2025 Earnings Call Transcript |
| 2025-11-14 | +3.7% | legal | SEC EDGAR | TELA 8-K: 1.01, 1.02, 2.03, 3.02 (SEC Filing) |
| 2025-11-14 | +3.7% | earnings | Investing.com | Piper Sandler lowers TELA Bio stock price target to $1.25 on soft Q3 results - Investing.com |
| 2025-11-14 | +3.7% | news | simplywall.st | Positive Sentiment Still Eludes TELA Bio, Inc. (NASDAQ:TELA) Following 26% Share Price Slump - simplywall.st |
| 2022-08-17 | +3.6% | legal | SEC EDGAR | TELA 8-K: 1.01 and (SEC Filing) |
| 2023-05-11 | -3.3% | legal | SEC EDGAR | TELA 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-04-20 | +3.3% | legal | SEC EDGAR | TELA 8-K: 1.01 and (SEC Filing) |
| 2021-11-10 | -3.0% | legal | SEC EDGAR | TELA 8-K: 2.02, 7.01 (SEC Filing) |
| 2024-05-20 | -2.9% | legal | SEC EDGAR | TELA 8-K: 8.01 and (SEC Filing) |
| 2026-03-23 | -2.9% | earnings | GuruFocus.com | TELA Bio Inc (TELA) Q4 2025: Everything You Need To Know Ahead Of Earnings |
| 2021-05-28 | -2.6% | news | TradingView | TELA Stock Price and Chart — NASDAQ:TELA - TradingView |
| 2024-04-15 | +2.4% | legal | SEC EDGAR | TELA 8-K: 8.01 and (SEC Filing) |
| 2022-08-19 | +2.4% | news | VISTA.Today | Malvern Med-Tech Company Expected to Raise $32 Million in Public Stock Offering - VISTA.Today |
| 2023-08-16 | +2.3% | legal | SEC EDGAR | TELA 8-K: 8.01 and (SEC Filing) |
| 2024-02-12 | +2.3% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2024-11-08 | -2.2% | earnings | Seeking Alpha | TELA Bio GAAP EPS of -$0.42 beats by $0.03, revenue of $18.96M beats by $0.11M |
| 2021-06-07 | +2.1% | legal | SEC EDGAR | TELA 8-K: 5.02 and 5.07 (SEC Filing) |
| 2021-05-19 | -2.1% | legal | SEC EDGAR | TELA 8-K: 8.01 and (SEC Filing) |
| 2024-06-06 | -2.0% | legal | SEC EDGAR | TELA 8-K: 5.02, 5.07, 8.01 (SEC Filing) |
| 2024-02-01 | -1.9% | analyst | eToro | TELA Bio Inc (TELA) Stock Price, News & Analyst Forecast - eToro |
| 2025-03-31 | +1.9% | legal | SEC EDGAR | TELA 8-K: 8.01 and (SEC Filing) |
| 2025-10-09 | -1.6% | legal | SEC EDGAR | TELA 8-K: 5.02 (SEC Filing) |
| 2025-12-14 | -1.6% | earnings | AD HOC NEWS | Tela Bio Shares Struggle Amid Lowered Guidance and Market Pressure - AD HOC NEWS |
| 2023-09-28 | +1.6% | legal | SEC EDGAR | TELA 8-K: 5.02 (SEC Filing) |
| 2023-10-20 | -1.5% | legal | SEC EDGAR | TELA 8-K: 1.01 (SEC Filing) |
| 2026-04-21 | -1.3% | news | GlobeNewswire | TELA Bio to Announce First Quarter 2026 Financial Results |
| 2026-04-21 | -1.3% | earnings | Stock Titan | TELA Bio plans a May 12 webcast to unpack quarterly results - Stock Titan |
| 2024-03-20 | -1.3% | legal | SEC EDGAR | TELA 8-K: 8.01 and (SEC Filing) |
| 2024-11-01 | +1.2% | executive | Scott Coop | TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Scott Coop |
| 2023-02-21 | +1.1% | legal | SEC EDGAR | TELA 8-K: 8.01 and (SEC Filing) |
| 2021-11-09 | -1.0% | legal | SEC EDGAR | TELA 8-K: 8.01 and (SEC Filing) |
| 2022-10-26 | +0.9% | legal | SEC EDGAR | TELA 8-K: 8.01 and (SEC Filing) |
| 2023-03-23 | +0.9% | legal | SEC EDGAR | TELA 8-K: 8.01 and (SEC Filing) |
| 2026-03-25 | -0.7% | earnings | Moby | TELA Bio, Inc. Q4 2025 Earnings Call Summary |
| 2026-03-25 | -0.7% | earnings | GuruFocus.com | TELA Bio Inc (TELA) Q4 2025 Earnings Call Highlights: Record Revenue Growth Amid Strategic ... |
| 2026-03-25 | -0.7% | earnings | Benzinga | TELA Bio Analysts Cut Their Forecasts After Q4 Results - Benzinga |
| 2026-03-25 | -0.7% | analyst | Investing.com | Jefferies cuts TELA Bio stock price target on slower growth outlook - Investing.com |
| 2026-03-25 | -0.7% | analyst | Investing.com | Piper Sandler cuts TELA Bio stock price target on lowered outlook - Investing.com |
| 2026-03-25 | -0.7% | analyst | GuruFocus | Piper Sandler Lowers Price Target for TELA Bio (TELA) to $1.00 | - GuruFocus |
| 2026-03-25 | -0.7% | analyst | Benzinga | Amazon To Rally Around 49%? Here Are 10 Top Analyst Forecasts For Wednesday - Amazon.com (NASDAQ:AMZN), A - Benzinga |
| 2024-11-07 | +0.6% | legal | SEC EDGAR | TELA 8-K: 2.02, 7.01 (SEC Filing) |
| 2021-11-01 | +0.5% | legal | SEC EDGAR | TELA 8-K: 8.01 and (SEC Filing) |
| 2024-05-11 | +0.5% | earnings | Seeking Alpha | TELA Bio, Inc. (TELA) Q1 2024 Earnings Call Transcript |
| 2024-01-16 | +0.5% | earnings | Seeking Alpha | TELA Bio: Looks Like A Buy, But Some Pieces Missing To Make This A Strong Buy - Seeking Alpha |
| 2021-05-13 | +0.4% | legal | SEC EDGAR | TELA 8-K: 2.02, 5.02, 7.01 (SEC Filing) |
| 2021-09-27 | +0.4% | legal | SEC EDGAR | TELA 8-K: 5.02 and (SEC Filing) |
| 2025-12-22 | -0.2% | news | Seeking Alpha | Becton, Dickinson accused of hindering competition in hernia mesh market |
| 2022-03-03 | -0.2% | legal | SEC EDGAR | TELA 8-K: 8.01 and (SEC Filing) |
| 2026-01-23 | +0.1% | news | Stock Titan | TELA Bio hands new hires 14,250 stock units that vest over 4 years - Stock Titan |